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INTRODUCTION
Autologous fat grafting is a well-accepted and useful 
adjunct for reconstructive and aesthetic breast surgery. Its 
role as a natural filler material has demonstrated success 
for volume enhancement, contour correction, and regen-
erative capability.1 Its efficacy to improve the quality of 
damaged skin following radiation therapy has been espe-
cially noteworthy and has demonstrated predictability and 
reproducibility in properly selected patients.2
Despite the widespread acceptance and utility of 
autologous fat grafting, there is tremendous variability 
in the harvesting, processing, and injection techniques 
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Background: Autologous fat grafting has broad applications in reconstructive and 
aesthetic breast surgery as a natural filler and for its regenerative purposes. Despite 
the widespread use of fat grafting, there remains no shared consensus on what con-
stitutes the optimal fat grafting technique and its oncological safety. For this reason, 
the authors of this study have organized a Survey and an International Consensus 
Conference that was held at the Aesthetic Breast Meeting in Milan (December 15, 
2018).
Methods: All studies on fat grafting, both for breast aesthetic and reconstructive 
purposes, were electronically screened. The literature review led to 17 “key ques-
tions” that were used for the Survey. The authors prepared a set of 10 “key state-
ments” that have been discussed in a dedicated face-to-face session during the 
meeting.
Results: The 10 key statements addressed all the most debated topics on fat graft-
ing of the breast. Levels of evidence for the key statements ranged from III to IV 
with 2 statements (20%) supported by a level of evidence III and 6 statements 
(60%) by level of evidence IV. Overall consensus was reached for 2 statements 
(20%) with >75% agreement reached for 7 statements.
Conclusions: The survey demonstrated a diversity of opinion and attitude among 
the panelists with regard to technique. Clear recommendations for evidence-based 
clinical practice for fat grafting use both in aesthetic and reconstructive breast sur-
gery could not be defined due to the scarcity of level 1 or 2 studies. (Plast Reconstr 
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without strong level of evidence (LoE) to support one 
technique over another.3 Although efficacy has been 
demonstrated in the majority of studies, concerns about 
oncological safety remain due to discrepancies reported 
in experimental and clinical studies.4 In addition, po-
tential complications of autologous fat grafting include 
fat necrosis, calcifications, and oil cyst formation all of 
which can potentially interfere with the detection of 
breast cancer and the surveillance of patients with a his-
tory of breast cancer.5
The heterogeneity associated with these studies is fur-
ther complicated by assessing outcomes using nonstan-
dardized and subjective methods.6
As a result of these shortcomings, the authors created a 
survey and organized an International Consensus Confer-
ence at the Maurizio Bruno Nava (MBN) 2018 Aesthetic 
Breast Meeting that was held in Milan, Italy, on Decem-
ber 15, 2018.7 The participants included plastic surgeons, 
breast surgeons, and radiation oncologists from around 
world who perform autologous fat grafting or evaluate 
patients on a regular basis. The intent of the consensus 
conference was to assess and understand the different at-
titudes toward fat grafting for aesthetic and reconstructive 
surgery of the breast to produce a consensus statement 
that was agreed upon and approved by all the internation-
al experts.
MATERIALS	AND	METHODS
The principle organizers (M.B.N., N.R., G.C.) per-
formed an electronic search of MEDLINE (1997 to June 
2018), EMBASE (1985 to June 2018), and the Cochrane 
Central Register of Controlled Trials (CENTRAL) with 
the launch of a specific search strategy (“Fat transplanta-
tion” or “Fat augmentation” or “Fat graft” or “Fat graft-
ing” or “Lipotransfer” or “Lipoaspirate” or “Lipofilling” 
or “Autologous Fat Graft” or “Autologous Fat Filler” or 
“Autologous Fat Grafting” or “Autogenous Fat Graft” or 
“Autologous Fat Transplant” or “Autologous Fat Trans-
plantation” or “Autogenous Fat Transplantation” or 
“Autogenous Fat Filler” or “Autogenous Fat Transfer” 
or “Adipose Harvest” or “Adipocyte Graft” or “Adipose 
Cell Transfer” or “Adipose Cellular Transplantation” or 
“Fat harvesting” or “Fat injection” or “Fat reinjection” or 
“Fat processing” or “Centrifugation” or “Decant” or “De-
cantation” or “breast surgery” or “breast” or “breast re-
construction” or “cosmetic breast surgery” or “aesthetic 
breast surgery”).
Two authors (N.R. and G.C.) independently reviewed 
the abstracts and selected all manuscripts that met the cri-
teria for inclusion based on the LoE. Selected manuscripts 
were scored from LoE I to V (according to Oxford crite-
ria).8 Inter-reviewer discordance was resolved with arbitra-
tion with a third author (M.B.N.).
Following the literature review, prominent areas of 
controversy and clinical uncertainty were identified and 
17 key questions (Table 1) were asked in a survey format 
and distributed to the international experts.
The international experts (Table 2) were invited ac-
cording to semiquantitative criteria that included:
• Coverage of different aspects of fat grafting (cosmetic 
and reconstructive issues, oncological issues, and radio-
logical issues);
• Surgical skills (renowned experience in breast cosmetic 
and reconstructive breast surgery and fat grafting use);
• Representatives from Europe and the Americas (North- 
and South-America);
• Authorship of peer-reviewed papers in the field of fat 
grafting for breast aesthetic and reconstructive purpos-
es in high impact factor journals.
Questions for the survey were sent via e-mail to the 
panelists 3 months preceding the conference, requesting 
their evidence-based answers. There were opportunities to 
suggest other relevant topics not already covered by the 
formulated questions.
Distribution of answers was calculated and graphically 
presented at the face-to-face session at the MBN2018 Aes-
thetic Breast Meeting. For each topic addressed in the key 
questions, the organizers produced a “Key Statement” with 
its LoE based on the highest LoE among the reviewed topic-
specific studies (Table 3).
This led to 10 “Key Statements” with corresponding 
LoE. The panelists discussed and expressed their opinion 
on each key statement in the face-to-face session through 
a dedicated bespoke web-based survey. The panelists were 
invited to record their agreement, disagreement, or ab-
stention for each key statement directly from their elec-
tronic devices (tablets, smartphones, or PC). This led to 
minor amendments of some key statements regarding 
their wording. Agreement of 75% or more with the state-
ment was considered as consensus among the panelists. 
Agreement from >50% to 74% was considered as a simple 
majority.
There was a further round of sharing of the key state-
ments in the month following the event with full accor-
dance with the final version of the key statements.
Table 1. Key Questions for the Survey
What is your favorite infiltration technique before fat harvesting?
Which are your decisional drivers for donor site choice?
What is your favorite harvesting technique?
What is your favorite method for fat processing?
Do you use any additional processing step to isolate, prepare, and 
store adipose stem cells?
Do you use any method of fat enrichment?
What is your favorite method for fat reinjection?
Do you use frozen fat?
Is there a significant correlation between fat grafting technique and 
clinical outcomes?
Which are the outcomes you consider when evaluating the results of 
your fat grafting procedures?
How do you measure your outcomes?
Is your opinion in fat grafting rate predictable?
Do you consider fat grafting to be a safe procedure after breast-
conserving treatment for breast cancer?
Do you consider fat grafting a safe procedure following mastectomy 
for breast cancer treatment?
Would you consider fat grafting use in BRCA-mutated patients?
What is your opinion in the role of fat grafting in aesthetic breast 
surgery?
What is your opinion in the impact of fat grafting procedures on 
breast cancer detection and surveillance?
BRCA, breast cancer.
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RESULTS
The systematic review of the literature identified 1,253 
peer-reviewed publications (see	figure,	Supplemental	Dig-
ital	Content	18, which displays literature review flow dia-
gram, http://links.lww.com/PRSGO/B214). After duplicates 
removal and exclusion of reviews, editorials, and commen-
taries, we assessed the LoE for 1,150 studies with only 5 
(0.4%) LoE I studies addressing key topics on fat graft-
ing.9–13 One hundred three studies (9%) were assessed as 
LoE II, 624 (54.2%) as LoE III, 348 (30.3%) as LoE IV, and 
70 (6.1%) as LoE V.
This review led to the identification of the key ques-
tions for the survey on fat grafting, with questions on (a) 
surgical technique; (b) regenerative purposes of fat graft-
ing; (c) clinical outcomes; (d) oncological safety of fat 
grafting; (e) the impact of fat grafting on breast cancer 
detection and surveillance; (f) fat grafting and aesthetic 
breast surgery.
The results of the survey and the distribution of the 
panelists’ answers are presented in Supplemental Digital 
Content. Question #1. What is your favorite infiltration 
technique before fat harvesting? (See	figure,	Supplemental	
Digital	Content	1, which displays survey results, http://links.
lww.com/PRSGO/B197). Question #2. Which are your deci-
sional drivers for donor site choice? (See	figure,	Supplemen-
tal	Digital	Content	2, which displays survey results, http://
links.lww.com/PRSGO/B198). Question #3. What is your 
favorite harvesting technique? (See	 figure,	 Supplemental	
Digital	Content	3, which displays survey results, http://links.
lww.com/PRSGO/B199). Question #4. What is your favorite 
method for fat processing? (See	figure,	Supplemental	Digi-
tal	Content	4, which displays survey results, http://links.lww.
com/PRSGO/B200). Question #5. Do you use any additional 
processing step to isolate, prepare and store adipose stem 
cells? (See	 figure,	 Supplemental	 Digital	 Content	 5, which 
displays survey results, http://links.lww.com/PRSGO/B201). 
Question #6. Do you use any method of fat enrichment? 
(See	figure,	Supplemental	Digital	Content	6, which displays 
survey results, http://links.lww.com/PRSGO/B202). Question 
#7. What is your favorite method for fat reinjection? (See	fig-
ure,	Supplemental	Digital	Content	7, which displays survey 
results, http://links.lww.com/PRSGO/B203). Question #8. Do 
you use frozen fat? (See	figure,	Supplemental	Digital	Con-
tent	 8, which displays survey results, http://links.lww.com/
PRSGO/B204). Question #9. Is there a significant correla-
tion between fat grafting technique and clinical outcomes? 
(See	figure,	Supplemental	Digital	Content	9, which displays 
survey results, http://links.lww.com/PRSGO/B205). Question 
#10. Which are the outcomes you consider when evaluating 
the results of your fat grafting procedures? (See	figure,	Sup-
plemental	Digital	Content	10, which displays survey results, 
http://links.lww.com/PRSGO/B206). Question #11. How do 
you measure your outcomes? (See	 figure,	 Supplemental	
Digital	 Content	 11, which displays survey results, http://
links.lww.com/PRSGO/B207). Question #12. Is your opinion 
in fat grafting rate predictable? (See	figure,	Supplemental	
Digital	Content	12, which displays survey results, http://links.
lww.com/PRSGO/B208). Question #13. Do you consider fat 
grafting to be a safe procedure after breast-conserving treat-
ment for breast cancer? (See	figure,	Supplemental	Digital	
Content	 13, which displays survey results, http://links.lww.
com/PRSGO/B209). Question #14. Do you consider fat graft-
ing a safe procedure following mastectomy for breast cancer 
treatment? (See	 figure,	 Supplemental	 Digital	 Content	 14, 
which displays survey results, http://links.lww.com/PRSGO/
B210). Question #15. Would you consider fat grafting use in 
BRCA-mutated patients? (See	figure,	Supplemental	Digital	
Content	 15, which displays survey results, http://links.lww.
com/PRSGO/B211). Question #16. What is your opinion 
in the role of fat grafting in aesthetic breast surgery? (See	
figure,	 Supplemental	 Digital	 Content	 16, which displays 
survey results, http://links.lww.com/PRSGO/B212). Question 
#17. What is your opinion in the impact of fat grafting pro-
cedures on breast cancer detection and surveillance?(See	
figure,	Supplemental	Digital	Content	17, which displays sur-
vey results, http://links.lww.com/PRSGO/B213). An overview 
about the panelists’ attitude toward different technical as-
pects of fat grafting is reported in Table 4.
The 10 key statements addressed the most debated top-
ics related to autologous fat grafting of the breast. State-
ments 1–5 address technical issues; statement 6 defines 
the role of stem cells in fat grafting; statement 7 defines 
the need of core outcome set use and standardized meth-
Table 2. Expert Panel Members
Name Nation Specialty
Phillip Blondeel Belgium Plastic and Reconstruc-
tive Surgeon
Giovanni Botti Italy Plastic and Reconstruc-
tive Surgeon
Francesco Casabona Italy Plastic and Reconstruc-
tive Surgeon
Giuseppe Catanuto Italy Breast Oncoplastic 
Surgeon
Mark Warren Clemens United States Plastic and Reconstruc-
tive Surgeon
Domenico De Fazio Italy Plastic and Reconstruc-
tive Surgeon
Roy De Vita Italy Plastic and Reconstruc-
tive Surgeon




United States Plastic and Reconstruc-
tive Surgeon
Paul Harris United Kingdom Plastic and Reconstruc-
tive Surgeon




Brazil Plastic and Reconstruc-
tive Surgeon
Maurice Nahabedian United States Plastic and Reconstruc-
tive Surgeon
Stefano Pompei Italy Plastic and Reconstruc-
tive Surgeon
Alberto Rancati Argentina Plastic and Reconstruc-
tive Surgeon
Gino Rigotti Italy Plastic and Reconstruc-
tive Surgeon





Andrea Spano Italy Plastic and Reconstruc-
tive Surgeon
Constantin Stan Romania Plastic and Reconstruc-
tive Surgeon
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ods for outcome assessment in fat grafting studies; state-
ment 8 addresses the use of fat grafting in aesthetic breast 
surgery; statement 9 underlines current evidences on fat 
grafting oncological safety; and statement 10 defines the 
safety of fat grafting in terms of breast cancer detection 
and surveillance.
Table 3. Key Statements on Fat Grafting of the Breast
Key	Statements LoE Agreements Disagreements Abstentions
1 No high LoE data about fat grafting are available in literature despite the 
great increase in fat grafting use over the past 20 years.
No evidence supports any specific procedural standardization (optimal donor site 
selection, infiltration, fat harvesting, fat processing, injection, fat storage).
Randomized controlled trials are required to understand which factors may 
significantly impact on fat grafting outcomes.
— 86% 14% —
2 The available evidence does not support any infiltration technique above 
another.
No significant effects of local anesthesia or epinephrine on fat graft have 
been demonstrated but local anesthetics may modulate isolated preadipo-
cytes viability rates.
Epinephrine/local anesthesia use should be based on pain relief and bleed-
ing control rather than fat cell viability.
IV 86% 14% —
3 The available evidence does not support any harvesting technique above 
another.
Low-pressure suction (<250 mm Hg) appears to increase adipocyte viability.
IV 79% 7% 14%
4 The available evidence does not support any processing technique above 
another.
When centrifugation is used, several studies suggest that forces >3,000 rpm 
cause more cellular damage.
IV 79% 7% 14%
5 a. Additional processing steps to isolate, prepare, and store adipose stem cells 
have not been sufficiently explored in a clinical setting.
We actually do not know the viability of the respective cell types (mature fat 
cells, adipose-derived stem cells, fibroblasts, and endothelial cells) between 
the various fat harvesting and processing techniques.
b. The respective roles that the different cell types play in fat graft take are 
not known.
In particular, there is no definitive evidence about any relationship between 
the number of adipose stem cells in the transferred fat and the fat grafting 
outcomes.
IV 93% — 7%
6 The actual evidence reports that frozen fat can be used for autologous fat 
transfer.
The addition of a cryoprotective agent and the methodology of freezing/ 
defreezing could significantly impact on cell viability.
IV 43% 7% 50%
7 A core outcome set for fat grafting has been recently identified.
It is recommended for researchers to use the core outcome set to choose appro-
priate and standardized outcomes when conducting clinical trials on fat graft-
ing, with the aim of reducing reporting bias and facilitating data synthesis.
There is a primary need for identifying appropriate methods for objective and 
standardized outcome assessment
— 93% 7% —
8 Fat grafting is a useful tool in aesthetic breast surgery in association 
to implants (composite/hybrid breast augmentations) or for minor 
 refinements.
Fat grafting could be also considered as an alternative to implants for breast 
augmentation with adequate patient information about the achievable 
results and the number of sessions needed
IV 93% 7% —
9 a. Oncological concerns have risen with the use of fat grafting for breast 
reconstruction.
There is an evident contradiction between experimental and clinical findings 
about the oncological safety of fat grafting.
The very complex interplay “in vivo” is not simulated in “in vitro” studies.
b. Fat grafting could be considered a safe procedure after breast-conserving 
treatment and mastectomy for breast cancer treatment with an adequate 
postoperative surveillance.
Prospective clinical trials with adequate follow-up are awaited to definitely 
confirm the safety of fat grafting in BRCA-mutated patients (both following 






10 Fat grafting is a safe procedure when considering the impact on breast cancer 
detection and surveillance if a proper technique is used and the surveil-
lance is granted by dedicated breast imaging specialists.
III 100% — —
LoE, level of evidence.
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For the purpose of clarity, 2 statements have been split 
(statements 5 and 9). Levels of evidence for the key state-
ments ranged from III to IV with 2 statements (20%) sup-
ported by LoE III and 6 statements (60%) by LoE IV. Two 
statements (ie, 1 and 7) are not associated to LoE because 
they do not present data deriving from the analysis of pub-
lished papers but general information about the quality 
of the evidence on fat grafting of the breast and the pub-
lished core outcome set.
Overall consensus was reached for 2 statements (20%) 
with >75% agreement reached for 7 statements. The low-
est level of agreement was related to fat storage and fro-
zen fat use (43% agreement, 7% disagreement, and 50% 
abstention).
CONCLUSIONS
The survey on fat grafting of the breast demonstrated 
a diversity of attitudes among the panelists with a great 
heterogeneity in the outcomes considered to evaluate the 
results of the performed procedures and in most cases 
subjective nonstandardized methods for outcome assess-
ment.
Tumescent technique using the Klein Solution (saline, 
lidocaine 0.1%, epinephrine 1/1,000,000) was the most 
commonly used technique for infiltration before fat har-
vesting and was the preferred technique for 39% of the 
panelists.
Some authors investigated the effect of epinephrine 
and lidocaine on human fat viability, concluding that the 
use of epinephrine and lidocaine did not have a significant 
effect on cell attachment in culture, cell morphology, pro-
liferation, or adipocyte metabolic activity.14,15 These find-
ings were confirmed by other authors who investigated fat 
cell viability with different epinephrine doses.16 Contrary to 
these findings, some researchers examined isolated preadi-
pocytes from fat and found that cell viability was reduced 
with lidocaine, ropivacaine, and prilocaine.17 They dem-
onstrated that local anesthetics significantly impaired pre-
adipocyte differentiation into mature adipocytes, with the 
exception of bupivacaine.18 With this knowledge in mind 
before the consensus meeting, some panelists (11%) pre-
ferred to use a modified Klein solution without local anes-
thetics whereas others chose not to use epinephrine (6%).
According to the survey results, fat availability was the 
main driver for donor site choice (57% of the panelists), 
followed by the patient’s preference (30%). Some panel-
ists chose the closest site to the receiving area based on the 
notion of “similarity” of the closest fat (7%). No significant 
differences in terms of cell viability have been demonstrat-
ed in relation with the area (abdomen, flank, thigh, and 
medial knee) where the fat is grafted.19 Some authors have 
demonstrated an increased concentration of adipose stem 
cells in fat harvested from the knees compared with other 
anatomical locations. The same authors also demonstrat-
ed that the superficial fat (ie, the fat situated above the fas-
cia superficialis) was richer in stem cells when compared 
with the fat below the fascia superficialis.20
The panelists underscored the importance of preserv-
ing the abdominal donor site in reconstructive patients as 
autologous flaps from the abdomen (ie, DIEP flap) can be 
considered in the event of a failed implant-based breast 
reconstruction.
With regard to the technique for fat harvesting, 
manual aspiration with 3–4 mm diameter cannulas and 
10–50 cm3 syringes was the most commonly performed 
technique (29% and 25%, respectively), followed by low-
pressure pump-assisted techniques (25%). The panelists 
also emphasized the importance of the diameter of the 
fenestrations within the aspiration cannula as larger diam-
eter fenestrations are associated with less mechanical trau-
ma to the fat and improved fat retention and outcomes.
Several authors studied the impact of the harvesting 
technique on fat grafting outcomes. Comparisons among 
various cannulas, needles, suction pressures, external ul-
trasound, and the utility of preoperative massage on cell vi-
ability was studied and demonstrated >10% damage when 
a −700 mm Hg vacuum was used.21 Additional studies have 
compared syringe liposuction to pump-assisted liposuction 
and demonstrated no differences in terms of cell viability 
or cell metabolic activity.22 When comparing cannula di-
ameter, studies have demonstrated increased cell viability 
using a 4-mm cannula compared with a 2- or 3-mm can-
nula.23,24 Pu et al.25 compared the Coleman technique to 
conventional liposuction and demonstrated significantly 
higher adipocyte viability in the Coleman cohort.
Decantation is the most frequently used technique for 
fat processing by the panelists (39%), followed by washing 
and filtration using closed sterile devices (22%). Most of 
the panelists using decantation commented on the ben-
efits of simpler techniques for fat processing after trying 
different techniques without finding any difference in the 
final outcome. Only 6% of the panel preferred centrifuga-
tion for fat processing using the modified Coleman tech-
niques.13,17–28
Table 4. Fat Grafting Technique: The Panelists’ Attitude
What	Is	Your	Favorite	
Technique	for: 	
Infiltration Tumescent Klein Solution 39%
 Super wet technique 17%
 Tumescent without local anesthetics 11%
 Power-assisted techniques 11%
 Tumescent without epinephrine 6%
 No infiltration 6%
Harvesting >3-mm cannulas 29%
 Low-pressure pump assisted 25%
 Manual aspiration with 10–50 ml syringe 25%
 <3-mm cannulas 11%
 Power assisted 4%
Fat processing Decantation 39%
 Wash and filter (closed sterile devices) 22%
 Wash and filter (no closed sterile devices) 17%
 Filtration (closed sterile devices) 6%
 Centrifugation (various rpm and timings) 6%
Reinjection 1- to 2-mm cannulas and 10 cm3 syringes 33%
 12/14 G needles and 10 cm3 syringes 22%
 12/14 G needles and 1–3 cm3 syringes 15%
 1- to 2-mm cannulas and 1–3 cm3 syringes 11%
 19/23 G needles and 1–3 cm3 syringes 7%
 Assisted fat delivery (Celbrush, etc.) 4%
Data are from the MBN 2018 Survey on fat grafting.
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In a randomized controlled trial that compared centri-
fuged versus noncentrifuged fat, the centrifuged cohort 
demonstrated a significant advantage based on fat reten-
tion at 5 months.13 Rohrich et al.19 disputed these findings 
demonstrating no significant differences in cell viability 
between centrifuged (500g for 2 minutes) and noncen-
trifuged samples.26 Ferraro et al.27 compared the Cole-
man technique (3,000 rpm for 3 minutes), their personal 
 technique (1,300 rpm for 5 minutes) and simple decanta-
tion of fat, demonstrating a significantly higher intake rate 
with their own technique. Others have compared differ-
ent timing of centrifugation at 50g (2, 4, 6, and 8 minutes) 
and demonstrated that centrifugation beyond 2 minutes 
did not increase the number and proportion of viable 
adipocytes.28 Other studies have compared centrifugation 
(1,500 rpm for 5 minutes) to an open method using a cot-
ton towel,29 and demonstrated no differences in fat graft-
ing weight and volume after 16 weeks when injected into 
nude mice. Rose et al.30 compared adipocyte viability us-
ing different methods of fat processing (washing, centrifu-
gation, or sedimentation) and demonstrated that intact 
adipocytes and nucleated adipocytes were significantly 
greater in samples processed by sedimentation. Other 
researchers investigated the effects of centrifugation on 
liposuction aspirates (various g forces for 3 minutes or 
noncentrifuged) and demonstrated that the optimal cen-
trifugal force is 1,200g (3,000 rpm).31 Condé-Green et al.32 
studied the influence of decantation, washing, and cen-
trifugation (3,000 rpm for 3 minutes) on adipocyte and 
adipose stem cells content of aspirated adipose tissue, 
concluding that adipocyte counts were significantly great-
er in decanted lipoaspirates compared with centrifuged 
lipoaspirates.
With regard to injection cannulas and syringe volume, 
the panelists showed a preference (33%) toward 1–2 mm 
Coleman cannulas and 10 cm3 syringes for fat reinjection 
with 22% preferring to use 12/14 gauge needles (diam-
eter 2.06 and 1.63 mm, respectively) and 10 cm3 syringes. 
only 7% of the panel preferred using assisted fat delivery 
systems (Celbrush, Cytori Therapeutics Inc.).
Few studies have investigated the different methods of 
fat reinjection. Ozsoy et al.23 compared 3 different Cole-
man-type cannulas of variable diameter and demonstrated 
increased adipocyte viability with 2.5 mm diameter can-
nula compared with the smaller diameters (1.6 or 2 mm). 
Erdim et al.24 compared 3 needles based on variable di-
ameters for reinjection (14, 16 and 20 gauge) and found 
no significant differences between needle gauge and cell 
viability.
Fat storage and frozen fat were not routinely used by 
any member of the panel despite literature alluding to fat 
storage as a viable option. Matsumoto et al.33 compared 
cell viability of adipose tissue in different storage tempera-
tures and observed that preservation for 4 hours at room 
temperature significantly damaged adipocytes but that ad-
ipose stem cells remained unchanged. Adipose stem cell 
yield from cryopreserved fat was decreased compared with 
fresh isolated aspirated fat. The authors concluded that as-
pirated fat could be transported to a cell-processing center 
for cell isolation on the day after harvesting and for sub-
sequent tissue banking if it is kept at 4°C. The methodol-
ogy for freezing significantly impacted the process. Other 
authors demonstrated no significant difference between 
fat graft mixed with cryoprotective agents and fresh graft 
in terms of adipocyte viability.34 All available studies have 
concluded that frozen fat can be used for autologous fat 
transfer but the addition of a cryoprotective agent and a 
strict methodology of freezing could improve cell viability.
The large majority (88%) of the panel did not use any 
method to isolate, prepare, and store adipose stem cells 
and only 8% of the panelists use fat-enrichment tech-
niques. Some authors have described the technique used 
for enrichment as a “self-enrichment,” mixing the fat of 
the deep layer (under the fascia superficialis) with the su-
perficial fat, potentially richer in stem cells.20
Only 7% of the panel considered fat grafting reten-
tion rate to be completely predictable with the majority of 
panelists (53%) agreeing that retention of grafted fat was 
not completely predictable and was dependent on patient 
characteristics and comorbidities, adjuvant therapies, and 
fat grafting technique.
The majority of the panel (69%) agreed that there 
was a significant correlation between the fat grafting tech-
nique and clinical outcomes.
There was significant variability among the panelists 
with regard to outcome assessment following autologous 
fat grafting. The breakdown is listed below:
• fat intake/survival (30%);
• aesthetic outcome of the recipient site (shape/volume/
symmetry) (22%);
• regenerative effects on damaged tissues (19%);
• patients’ satisfaction levels and quality of life 
(QoL; 11%);
• aesthetic outcomes of the donor site (8%);
• fat necrosis in the recipient site (8%).
Methods for measuring outcomes reported by the pan-
elists are distributed as follows:
• clinical assessment (35%);
• preoperative/postoperative standard pictures (30%);
• preoperative/postoperative magnetic resonance imag-
ing (10%);
• preoperative/postoperative 3-dimensional pictures 
(10%);
• nonvalidated questionnaires for satisfaction level and 
QoL assessment (10%);
• Lent-Soma Scale for radiation damage (5%).
A core outcome set for fat grafting has been recently 
identified with a strict methodology, listing oncological 
(rate of locoregional cancer recurrence), clinical (all 
complications assessed with Clavien-Dindo grading), aes-
thetic (surgeon assessed), functional (EQ-D5, BREAST-
Q), patient-reported (BREAST-Q), process (number of 
fat grafting sessions need to get optimal result), and 
radiological outcomes (incidence of radiological ab-
normalities, interference with mammography) as key 
outcome to consider when evaluating the results of fat 
grafting procedures.6
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It is recommended for researchers to use the core 
outcome set to choose appropriate and standardized out-
comes when conducting clinical trials on fat grafting,35 
with the aim of reducing reporting bias and facilitating 
data synthesis among different studies.
The panelists emphasized the importance of identi-
fying objective and standardized methods for outcome 
assessment, going beyond simple clinical assessment, 
 preoperative/postoperative standard pictures or 
 nonvalidated questionnaires for satisfaction level, and 
QoL assessment.
Oncological concerns have risen about the safety of fat 
grafting after breast cancer surgery. A recent systematic 
review4 reported data deriving from 18 clinical studies,36–53 
showing locoregional recurrence rates (LRR) between 0% 
and 3.9% per year following breast-conserving treatment 
and mastectomy plus fat grafting. LRR per year between 
0% and 1.62% has been reported following mastectomy 
plus fat grafting and between 0% and 3.9% following 
breast-conserving treatment plus fat transfer. Some of the 
included studies considered a matched control group 
finding no significant difference between cases and con-
trols with the exception of a subgroup of patients with in 
situ breast carcinoma.38
These concerns derive from the potential interaction 
between adipose-derived mesenchymal stem cells within 
the transferred fat and primary breast cancer cells in af-
ter breast cancer surgery. Several adipokines have been 
reported to potentially promote tumor initiation and 
growth, but clinical studies did not show any significant in-
crease in LRR in patients receiving fat grafting after breast 
cancer surgery.
There are a clear discrepancy and contradiction be-
tween experimental and clinical findings with regard to 
the oncological safety of autologous fat grafting. It is ev-
ident that there is a very complex interplay that occurs 
“in vivo” that may not be accurately duplicated with the 
“in-vitro” studies. The role and impact of radiotherapy 
and systemic therapies cannot be simulated with “in vitro” 
studies.54
The majority of panelists consider fat grafting a safe 
procedure after breast-conserving surgery (69%) and mas-
tectomy (86%) for breast cancer treatment. Fat grafting 
was also considered safe in patients with the BRCA muta-
tion (71%), as long as adequate postoperative follow-up is 
maintained.
The safety and effectiveness of fat grafting of the breast 
have also been questioned with regard to the development 
of fat necrosis, calcifications, and oil cysts, all of which can 
potentially interfere with the detection of breast cancer 
and surveillance of patients following surgery for breast 
cancer. However, there is ample evidence that supports 
the safety and effectiveness of fat grafting of the breast in 
terms of breast cancer detection and surveillance.55–64
The majority of the panelists (75%) stated that fat 
grafting represents a safe procedure when considering 
the impact on breast cancer detection and surveillance if 
a proper technique for grafting is used and the follow-up 
is granted by dedicated breast imaging specialists. Twenty-
five percent of the panelists consider fat grafting safe in 
terms of breast cancer detection and surveillance, with 
the need of informing the patient about the possibility 
of higher second level examination rates (magnetic reso-
nance imaging/biopsies).
Fat grafting use has been also described as an alter-
native to implants or in association to implants for com-
posite/hybrid procedures for breast augmentation, or 
as a useful tool for minor refinements following breast 
 augmentation with implants. Forty peer-reviewed articles 
have been published investigating the use of fat grafting 
for cosmetic breast augmentation.59,65–103 Most studies 
showed a low LoE, with only 1 level II study103 in only 10 
patients. Indications for fat grafting were mostly aesthetic 
augmentations (92.4%) and corrections of congenital 
malformations (7.6%).
The majority of the panelists consider fat grafting to 
be a useful tool in aesthetic breast surgery in conjunction 
to implants (composite/hybrid augmentations) (41%) or 
for minor refinements (41%). Only 19% considered fat 
grafting to be a reliable alternative to implants for breast 
augmentation. The important factors included adequate 
patient information about the achievable results and the 
need for multiple procedures.
In particular, Rigotti et al.104 presented and discussed a 
new minimally invasive approach toward breast aesthetic 
surgery, called biological morphogenetic surgery that ex-
ploits the physiological mechanisms of tissue repair and 
the interaction between the transferred fat and the host 
tissue to reach a shape enlargement or reduction depend-
ing on the patient’s surgical needs and requests, following 
a mild surgical injury.
In summary, the consensus conference demonstrated 
high levels of agreement among panel of experts with 
>75% being in agreement for 9 of 10 statements. The only 
statement that demonstrated a lack of consensus was in re-
gard to fat storage with only a 43% agreement and a 50% 
abstention rate. The explanation for the high abstention 
rate was based on the lack of experience with frozen fat as 
the majority had never utilized fat storage.
Our consensus conference presents some limitations, 
as the literature behind each key statement has not been 
assessed with a standardized methodology (ie, GRADE 
method),105 but only the LoE according to Oxford Criteria8 
has been evaluated. Thus our conclusions only remain the 
expression of the opinion of a group of experts on some 
statements on fat grafting of the breast, not being guide-
lines for clinical practice. Another limit is represented by 
choice of the panel that could be not representative of the 
entire world, in particular with the absence of experts com-
ing from Asia, where fat grafting is widely used.106
Clear recommendations for evidence-based clinical 
practice for fat grafting use both in aesthetic and recon-
structive breast surgery could not be defined due to the 
scarcity of good quality and high LoE studies addressing 
technical issues related with fat grafting.
The panelists concluded that higher quality and LoE 
studies, better if randomized controlled trials, are strongly 
awaited to support procedural standardization in terms 
of optimal donor site selection, infiltration technique, fat 
harvesting, fat processing, injection and storage, and to 
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better understand which factors may significantly impact 
on fat grafting outcomes.
Prospective studies, better if randomized controlled 
trials, with adequate follow-up are also awaited to defini-
tively confirm the oncological safety of fat grafting follow-
ing breast cancer surgery in particular in BRCA-mutated 
patients and to further approve the safety of fat grafting in 
terms of breast cancer detection and surveillance.
Nicola Rocco, MD






 1. Coleman SR. Structural fat grafts: the ideal filler? Clin Plast Surg. 
2001;28:111–119.
 2. Zhou Y, Wang J, Li H, et al. Efficacy and safety of cell-assisted 
lipotransfer: a systematic review and meta-analysis. Plast Reconstr 
Surg. 2016;137:44e–57e. 
 3. Gir P, Brown SA, Oni G, et al. Fat grafting: evidence-based review 
on autologous fat harvesting, processing, reinjection, and stor-
age. Plast Reconstr Surg. 2012;130:249–258. 
 4. Waked K, Colle J, Doornaert M, et al. Systematic review: the 
oncological safety of adipose fat transfer after breast cancer sur-
gery. Breast. 2017;31:128–136. 
 5. Groen JW, Negenborn VL, Twisk JW, et al. Autologous fat 
grafting in cosmetic breast augmentation: a systematic review 
on radiological safety, complications, volume retention, and 
patient/surgeon satisfaction. Aesthet Surg J. 2016;36:993–1007. 
 6. Agha RA, Pidgeon TE, Borrelli MR, et al; VOGUE Group. 
Validated outcomes in the grafting of autologous fat to the 
breast: the VOGUE study. Development of a core outcome set 
for research and audit. Plast Reconstr Surg. 2018;141:633e–638e. 
 7. MBN. Aesthetic breast meeting. http://congress.maurizionava.
it/wp-content/uploads/2018/03/TIME_TABLE_MBN_2018.
pdf. Accessed January 2019.
 8. Centre for Evidence-Based Medicine. Oxford centre for evi-
dence-based medicine – Levels of evidence (March 2009). 
https://www.cebm.net/2009/06/oxford-centre-evidence-based-
medicine-levels-evidence-march-2009/. Accessed January 2019.
 9. Sarfati I, van la Parra RFD, Terem-Rapoport CA, et al. A prospec-
tive randomized study comparing centrifugation and sedimen-
tation for fat grafting in breast reconstruction. J Plast Reconstr 
Aesthet Surg. 2017;70:1218–1228. 
 10. Juhl AA, Karlsson P, Damsgaard TE. Fat grafting for alleviating 
persistent pain after breast cancer treatment: a randomized con-
trolled trial. J Plast Reconstr Aesthet Surg. 2016;69:1192–1202. 
 11. Mestak O, Sukop A, Hsueh YS, et al. Centrifugation versus pure-
graft for fatgrafting to the breast after breast-conserving therapy. 
World J Surg Oncol. 2014;12:178. 
 12. Kølle SF, Fischer-Nielsen A, Mathiasen AB, et al. Enrichment 
of autologous fat grafts with ex-vivo expanded adipose tissue-
derived stem cells for graft survival: a randomised placebo-con-
trolled trial. Lancet. 2013;382:1113–1120. 
 13. Khater R, Atanassova P, Anastassov Y, et al. Clinical and experi-
mental study of autologous fat grafting after processing by cen-
trifugation and serum lavage. Aesthetic Plast Surg. 2009;33:37–43. 
 14. Moore JH Jr, Kolaczynski JW, Morales LM, et al. Viability of fat 
obtained by syringe suction lipectomy: effects of local anesthesia 
with lidocaine. Aesthetic Plast Surg. 1995;19:335–339.
 15. Shoshani O, Berger J, Fodor L, et al. The effect of lido-
caine and adrenaline on the viability of injected adipose 
tissue–an experimental study in nude mice. J Drugs Dermatol. 
2005;4:311–316.
 16. Kim IH, Yang JD, Lee DG, et al. Evaluation of centrifugation 
technique and effect of epinephrine on fat cell viability in autol-
ogous fat injection. Aesthet Surg J. 2009;29:35–39. 
 17. Keck M, Janke J, Ueberreiter K. Viability of preadipocytes in 
vitro: the influence of local anesthetics and ph. Dermatol Surg. 
2009;35:1251–1257. 
 18. Keck M, Zeyda M, Gollinger K, et al. Local anesthetics have a 
major impact on viability of preadipocytes and their differentia-
tion into adipocytes. Plast Reconstr Surg. 2010;126:1500–1505. 
 19. Rohrich RJ, Sorokin ES, Brown SA. In search of improved fat 
transfer viability: a quantitative analysis of the role of centrifuga-
tion and harvest site. Plast Reconstr Surg. 2004;113:391–395; dis-
cussion 396–397. 
 20. Di Taranto G, Cicione C, Visconti G, et al. Qualitative and 
quantitative differences of adipose-derived stromal cells from 
superficial and deep subcutaneous lipoaspirates: a matter of fat. 
Cytotherapy. 2015;17:1076–1089. 
 21. Shiffman MA, Mirrafati S. Fat transfer techniques: the effect of 
harvest and transfer methods on adipocyte viability and review of 
the literature. Dermatol Surg. 2001;27:819–826. 
 22. Leong DT, Hutmacher DW, Chew FT, et al. Viability and 
adipogenic potential of human adipose tissue processed cell 
population obtained from pump-assisted and syringe-assisted 
liposuction. J Dermatol Sci. 2005;37:169–176. 
 23. Ozsoy Z, Kul Z, Bilir A. The role of cannula diameter in 
improved adipocyte viability: a quantitative analysis. Aesthet Surg 
J. 2006;26:287–289. 
 24. Erdim M, Tezel E, Numanoglu A, et al. The effects of the size 
of liposuction cannula on adipocyte survival and the optimum 
temperature for fat graft storage: an experimental study. J Plast 
Reconstr Aesthet Surg. 2009;62:1210–1214. 
 25. Pu LL, Coleman SR, Cui X, et al. Autologous fat grafts harvested 
and refined by the coleman technique: a comparative study. Plast 
Reconstr Surg. 2008;122:932–937. 
 26. Ramon Y, Shoshani O, Peled IJ, et al. Enhancing the take of 
injected adipose tissue by a simple method for concentrating fat 
cells. Plast Reconstr Surg. 2005;115:197–201; discussion 202.
 27. Ferraro GA, De Francesco F, Tirino V, et al. Effects of a new cen-
trifugation method on adipose cell viability for autologous fat 
grafting. Aesthetic Plast Surg. 2011;35:341–348. 
 28. Boschert MT, Beckert BW, Puckett CL, et al. Analysis of lipocyte 
viability after liposuction. Plast Reconstr Surg. 2002;109:761–765; 
discussion 766. 
 29. Smith P, Adams WP Jr, Lipschitz AH, et al. Autologous human 
fat grafting: effect of harvesting and preparation techniques on 
adipocyte graft survival. Plast Reconstr Surg. 2006;117:1836–1844. 
 30. Rose JG Jr, Lucarelli MJ, Lemke BN, et al. Histologic comparison 
of autologous fat processing methods. Ophthalmic Plast Reconstr 
Surg. 2006;22:195–200. 
 31. Kurita M, Matsumoto D, Shigeura T, et al. Influences of centrif-
ugation on cells and tissues in liposuction aspirates: optimized 
centrifugation for lipotransfer and cell isolation. Plast Reconstr 
Surg. 2008;121:1033–1041; discussion 1042. 
 32. Condé-Green A, de Amorim NF, Pitanguy I. Influence of decan-
tation, washing and centrifugation on adipocyte and mesenchy-
mal stem cell content of aspirated adipose tissue: a comparative 
study. J Plast Reconstr Aesthet Surg. 2010;63:1375–1381. 
 33. Matsumoto D, Shigeura T, Sato K, et al. Influences of preser-
vation at various temperatures on liposuction aspirates. Plast 
Reconstr Surg. 2007;120:1510–1517. 
 34. Son D, Oh J, Choi T, et al. Viability of fat cells over time after 
syringe suction lipectomy: the effects of cryopreservation. Ann 
Plast Surg. 2010;65:354–360. 
 Nava et al. • Fat Grafting of the Breast
9
 35. Salgarello M, Visconti G, Barone-Adesi L. Fat grafting and breast 
reconstruction with implant: another option for irradiated breast 
cancer patients. Plast Reconstr Surg. 2012;129:317–329. 
 36. Petit JY, Lohsiriwat V, Clough KB, et al. The oncologic outcome 
and immediate surgical complications of lipofilling in breast can-
cer patients: a multicenter study–milan-paris-lyon experience of 
646 lipofilling procedures. Plast Reconstr Surg. 2011;128:341–346. 
 37. Kronowitz SJ, Mandujano CC, Liu J, et al. Lipofilling of the 
breast does not increase the risk of recurrence of breast cancer: a 
matched controlled study. Plast Reconstr Surg. 2016;137:385–393. 
 38. Petit JY, Rietjens M, Botteri E, et al. Evaluation of fat grafting 
safety in patients with intraepithelial neoplasia: a matched-
cohort study. Ann Oncol. 2013;24:1479–1484. 
 39. Mestak O, Hromadkova V, Fajfrova M, Molitor M, Mestak J. 
Evaluation of oncological safety of fat grafting after breast con-
serving therapy: a prospective study. Ann Surg Oncol. 2015:776e81
 40. Petit JY, Botteri E, Lohsiriwat V, et al. Locoregional recur-
rence risk after lipofilling in breast cancer patients. Ann Oncol. 
2012;23:582–588. 
 41. Delay E, Gosset J, Toussoun G, et al. [Efficacy of lipomodelling 
for the management of sequelae of breast cancer conservative 
treatment]. Ann Chir Plast Esthet. 2008;53:153–168. 
 42. Sarfati I, Ihrai T, Kaufman G, et al. Adipose-tissue grafting 
to the post-mastectomy irradiated chest wall: preparing the 
ground for implant reconstruction. J Plast Reconstr Aesthet Surg. 
2011;64:1161–1166. 
 43. Delaporte T, Delay E, Toussoun G, et al. Breast volume recon-
struction by lipomodeling technique: about 15 consecutive cases. 
Ann Chir Plast Esthet. 2009;54:303e16. 
 44. Semprini G, Cattin F, Zanin C, et al. About locoregional recur-
rence risk after lipofilling in breast cancer patients: our experi-
ence. Minerva Chir. 2014;69:91–96.
 45. Gale KL, Rakha EA, Ball G, et al. A case-controlled study 
of the oncologic safety of fat grafting. Plast Reconstr Surg. 
2015;135:1263–1275. 
 46. Silva-Vergara C, Fontdevila J, Descarrega J, et al. Oncological out-
comes of lipofilling breast reconstruction: 195 consecutive cases 
and literature review. J Plast Reconstr Aesthet Surg. 2016;69:475–481. 
 47. Kaoutzanis C, Xin M, Ballard TN, et al. Autologous fat grafting 
after breast reconstruction in postmastectomy patients: compli-
cations, biopsy rates, and locoregional cancer recurrence rates. 
Ann Plast Surg. 2016;76:270–275. 
 48. Moltó García R, González Alonso V, Villaverde Doménech ME. 
Fat grafting in immediate breast reconstruction. Avoiding breast 
sequelae. Breast Cancer. 2016;23:134–140. 
 49. Rigotti G, Marchi A, Stringhini P, et al. Determining the oncolog-
ical risk of autologous lipoaspirate grafting for post-mastectomy 
breast reconstruction. Aesthetic Plast Surg. 2010;34:475–480. 
 50. Rietjens M, De Lorenzi F, Rossetto F, et al. Safety of fat grafting 
in secondary breast reconstruction after cancer. J Plast Reconstr 
Aesthet Surg. 2011;64:477–483. 
 51. Riggio E, Bordoni D, Nava MB. Oncologic surveillance of 
breast cancer patients after lipofilling. Aesthetic Plast Surg. 
2013;37:728–735. 
 52. Brenelli F, Rietjens M, De Lorenzi F, et al. Oncological safety of 
autologous fat grafting after breast conservative treatment: a pro-
spective evaluation. Breast J. 2014;20:159–165. 
 53. Ihrai T, Georgiou C, Machiavello JC, et al. Autologous fat graft-
ing and breast cancer recurrences: retrospective analysis of a 
series of 100 procedures in 64 patients. J Plast Surg Hand Surg. 
2013;47:273–275. 
 54. Klopp AH, Gupta A, Spaeth E, et al. Concise review: dissecting a 
discrepancy in the literature: do mesenchymal stem cells support 
or suppress tumor growth? Stem Cells. 2011;29:11–19. 
 55. Spear SL, Coles CN, Leung BK, et al. The safety, effectiveness, 
and efficiency of autologous fat grafting in breast surgery. Plast 
Reconstr Surg Glob Open. 2016;4:e827. 
 56. Bonomi R, Betal D, Rapisarda IF, et al. Role of lipomodelling in 
improving aesthetic outcomes in patients undergoing immedi-
ate and delayed reconstructive breast surgery. Eur J Surg Oncol. 
2013;39:1039–1045. 
 57. Choi M, Small K, Levovitz C, et al. The volumetric analysis of fat graft 
survival in breast reconstruction. Plast Reconstr Surg. 2013;131:185–191. 
 58. Seth AK, Hirsch EM, Kim JY, et al. Long-term outcomes follow-
ing fat grafting in prosthetic breast reconstruction: a compara-
tive analysis. Plast Reconstr Surg. 2012;130:984–990. 
 59. Veber M, Tourasse C, Toussoun G, et al. Radiographic find-
ings after breast augmentation by autologous fat transfer. Plast 
Reconstr Surg. 2011;127:1289–1299. 
 60. Caviggioli F, Maione L, Forcellini D, et al. Autologous fat graft in post-
mastectomy pain syndrome. Plast Reconstr Surg. 2011;128:349–352. 
 61. de Blacam C, Momoh AO, Colakoglu S, et al. Evaluation of clini-
cal outcomes and aesthetic results after autologous fat grafting 
for contour deformities of the reconstructed breast. Plast Reconstr 
Surg. 2011;128:411e–418e. 
 62. Hoppe DL, Ueberreiter K, Surlemont Y, et al. Breast reconstruc-
tion de novo by water-jet assisted autologous fat grafting–a retro-
spective study. Ger Med Sci. 2013;11:Doc17. 
 63. Pérez-Cano R, Vranckx JJ, Lasso JM, et al. Prospective trial of 
adipose-derived regenerative cell (ADRC)-enriched fat grafting 
for partial mastectomy defects: the RESTORE-2 trial. Eur J Surg 
Oncol. 2012;38:382–389. 
 64. Sinna R, Delay E, Garson S, et al. Breast fat grafting (lipomodel-
ling) after extended latissimus dorsi flap breast reconstruction: a 
preliminary report of 200 consecutive cases. J Plast Reconstr Aesthet 
Surg. 2010;63:1769–1777. 
 65. Bircoll M, Novack BH. Autologous fat transplantation employing 
liposuction techniques. Ann Plast Surg. 1987;18:327–329. 
 66. Bircoll M. Cosmetic breast augmentation utilizing autologous fat 
and liposuction techniques. Plast Reconstr Surg. 1987;79:267–271. 
 67. Hörl HW, Feller AM, Biemer E. Technique for liposuction fat 
reimplantation and long-term volume evaluation by magnetic 
resonance imaging. Ann Plast Surg. 1991;26:248–258. 
 68. Maillard GF. Liponecrotic cysts after augmentation mamma-
plasty with fat injections. Aesthetic Plast Surg. 1994;18:405–406.
 69. Castelló JR, Barros J, Vázquez R. Giant liponecrotic pseudocyst 
after breast augmentation by fat injection. Plast Reconstr Surg. 
1999;103:291–293. 
 70. Valdatta L, Thione A, Buoro M, et al. A case of life-threatening 
sepsis after breast augmentation by fat injection. Aesthetic Plast 
Surg. 2001;25:347–349. 
 71. Kwak JY. Sonographic identification of complications of cosmetic 
augmentation with autologous fat obtained by liposuction. Ann 
Plast Surg. 2004;64:385–389.
 72. Pulagam SR, Poulton T, Mamounas EP. Long-term clinical and 
radiologic results with autologous fat transplantation for breast 
augmentation: case reports and review of the literature. Breast J. 
2006;12:63–65. 
 73. Wang H, Jiang Y, Meng H, et al. Sonographic assessment on 
breast augmentation after autologous fat graft. Plast Reconstr 
Surg. 2008;122:36e–38e. 
 74. Carvajal J, Patiño JH. Mammographic findings after breast 
augmentation with autologous fat injection. Aesthet Surg J. 
2008;28:153–162. 
 75. Pinsolle V, Chichery A, Grolleau JL, et al. Autologous fat 
injection in Poland’s syndrome. J Plast Reconstr Aesthet Surg. 
2008;61:784–791. 
 76. Yoshimura K, Sato K, Aoi N, et al. Cell-assisted lipotransfer for 
cosmetic breast augmentation: supportive use of adipose-derived 
stem/stromal cells. Aesthetic Plast Surg. 2008;32:48–55; discussion 56. 
PRS Global Open • 2019
10
 77. Mu DL, Luan J, Mu L, et al. Breast augmentation by autologous 
fat injection grafting: management and clinical analysis of com-
plications. Ann Plast Surg. 2009;63:124–127. 
 78. Lazzaretti MG, Giovanardi G, Gibertoni F, et al. A late compli-
cation of fat autografting in breast augmentation. Plast Reconstr 
Surg. 2009;123:71e–72e. 
 79. Yoshimura K, Asano Y, Aoi N, et al. Progenitor-enriched adipose 
tissue transplantation as rescue for breast implant complications. 
Breast J. 2010;16:169–175. 
 80. Lee KS, Seo SJ, Park MC, et al. Sepsis with multiple abscesses 
after massive autologous fat grafting for augmentation mammo-
plasty: a case report. Aesthet Plast Surg. 2011;35:641–645. 
 81. Delay E, Sinna R, Chekaroua K, et al. Lipomodeling of Poland’s 
syndrome: a new treatment of the thoracic deformity. Aesthetic 
Plast Surg. 2010;34:218–225. 
 82. Talbot SG, Parrett BM, Yaremchuk MJ. Sepsis after autologous fat 
grafting. Plast Reconstr Surg. 2010;126:162e–164e. 
 83. Kim H, Yang EJ, Bang SI. Bilateral liponecrotic pseudocysts after 
breast augmentation by fat injection: a case report. Aesthetic Plast 
Surg. 2012;36:359–362. 
 84. Yang H, Lee H. Successful use of squeezed-fat grafts to cor-
rect a breast affected by Poland syndrome. Aesthetic Plast Surg. 
2011;35:418–425. 
 85. Kamakura T, Ito K. Autologous cell-enriched fat grafting for 
breast augmentation. Aesthetic Plast Surg. 2011;35:1022–1030. 
 86. Del Vecchio DA. “SIEF”–simultaneous implant exchange with 
fat: a new option in revision breast implant surgery. Plast Reconstr 
Surg. 2012;130:1187–1196. 
 87. La Marca S, Delay E, Toussoun G, et al. [Treatment of poland 
syndrome thorax deformity with the lipomodeling technique: 
about ten cases]. Ann Chir Plast Esthet. 2013;58:60–68. 
 88. Auclair E, Blondeel P, Del Vecchio DA. Composite breast aug-
mentation: soft-tissue planning using implants and fat. Plast 
Reconstr Surg. 2013;132:558–568. 
 89. Bulgin D, Vrabic E, Hodzic E. Autologous bone-marrow-derived-
mononuclear-cells-enriched fat transplantation in breast aug-
mentation: evaluation of clinical outcomes and aesthetic results 
in a 30-year-old female. Case Rep Surg. 2013;2013:782069. 
 90. Matsudo PK, Toledo LS. Experience of injected fat grafting. 
Aesthetic Plast Surg. 1988;12:35–38.
 91. Coleman SR, Saboeiro AP. Fat grafting to the breast revisited: safety 
and efficacy. Plast Reconstr Surg. 2007;119:775–785; discussion 786. 
 92. Zheng DN, Li QF, Lei H, et al. Autologous fat grafting to the 
breast for cosmetic enhancement: experience in 66 patients with 
long-term follow up. J Plast Reconstr Aesthet Surg. 2008;61:792–798. 
 93. Zocchi ML, Zuliani F. Bicompartmental breast lipostructuring. 
Aesthetic Plast Surg. 2008;32:313–328. 
 94. Delay E, Garson S, Tousson G, et al. Fat injection to the breast: 
technique, results, and indications based on 880 procedures over 
10 years. Aesthet Surg J. 2009;29:360–376. 
 95. Illouz YG, Sterodimas A. Autologous fat transplantation to the 
breast: a personal technique with 25 years of experience. Aesthetic 
Plast Surg. 2009;33:706–715. 
 96. Herold C, Ueberreiter K, Vogt PM. Brava and autologous fat 
transfer is a safe and effective breast augmentation alternative: 
results of a 6-year, 81-patient, prospective multicenter study. Plast 
Reconstr Surg. 2012;130:479e–480e. 
 97. Ueberreiter K, von Finckenstein JG, Cromme F, et al. 
[BEAULI™–a new and easy method for large-volume fat grafts]. 
Handchir Mikrochir Plast Chir. 2010;42:379–385. 
 98. Del Vecchio DA, Bucky LP. Breast augmentation using preexpan-
sion and autologous fat transplantation: a clinical radiographic 
study. Plast Reconstr Surg. 2011;127:2441–2450. 
 99. Khouri RK, Eisenmann-Klein M, Cardoso E, et al. Brava and 
autologous fat transfer is a safe and effective breast augmenta-
tion alternative: results of a 6-year, 81-patient, prospective multi-
center study. Plast Reconstr Surg. 2012;129:1173–1187. 
 100. Fiaschetti V, Pistolese CA, Fornari M, et al. Magnetic resonance 
imaging and ultrasound evaluation after breast autologous fat 
grafting combined with platelet-rich plasma. Plast Reconstr Surg. 
2013;132:498e–509e. 
 101. Khouri RK, Khouri RK Jr, Rigotti G, et al. Aesthetic applica-
tions of brava-assisted megavolume fat grafting to the breasts: a 
9-year, 476-patient, multicenter experience. Plast Reconstr Surg. 
2014;133:796–807; discussion 808. 
 102. Rubin JP, Coon D, Zuley M, et al. Mammographic changes after fat 
transfer to the breast compared with changes after breast reduc-
tion: a blinded study. Plast Reconstr Surg. 2012;129:1029–1038. 
 103. Spear SL, Pittman T. A prospective study on lipoaugmentation of 
the breast. Aesthet Surg J. 2014;34:400–408. 
 104. Rigotti G, Chirumbolo S. Biological morphogenetic surgery: a 
minimally invasive procedure to address different biological 
mechanisms. Aesthet Surg J. 2019;39:745–755. 
 105. Guyatt GH, Oxman AD, Vist GE, et al; GRADE Working Group. 
GRADE: an emerging consensus on rating quality of evidence 
and strength of recommendations. BMJ. 2008;336:924–926. 
 106. Heidekrueger PI, Sinno S, Hidalgo DA, et al. Current trends 
in breast augmentation: an international analysis. Aesthet Surg J. 
2018;38:133–148. 
